Lajollamycin, a nitro-tetraene spiro-beta-lactone-gamma-lactam antibiotic from the marine actinomycete Streptomyces nodosus

J Nat Prod. 2005 Feb;68(2):240-3. doi: 10.1021/np049725x.

Abstract

A strain of Streptomyces nodosus (NPS007994) isolated from a marine sediment collected in Scripps Canyon, La Jolla, California, was found to produce lajollamycin (1), a nitro-tetraene spiro-beta-lactone-gamma-lactam antibiotic. The structure was established by complete analysis of spectroscopic data and comparison with known antibiotics oxazolomycin (2), 16-methyloxazolomycin (3), and triedimycin B (4). Lajollamycin (1) showed antimicrobial activity against both drug-sensitive and -resistant Gram-positive bacteria and inhibited the growth of B16-F10 tumor cells in vitro.

MeSH terms

  • Animals
  • Anti-Bacterial Agents / chemistry
  • Anti-Bacterial Agents / isolation & purification*
  • Anti-Bacterial Agents / pharmacology
  • Antineoplastic Agents / chemistry
  • Antineoplastic Agents / isolation & purification*
  • Antineoplastic Agents / pharmacology
  • California
  • Cell Line, Tumor
  • Drug Screening Assays, Antitumor
  • Gram-Positive Bacteria / drug effects
  • Lactams / chemistry
  • Lactams / isolation & purification*
  • Lactams / pharmacology
  • Mice
  • Microbial Sensitivity Tests
  • Molecular Structure
  • Oxazoles / chemistry
  • Polyunsaturated Alkamides
  • Spiro Compounds / chemistry
  • Spiro Compounds / isolation & purification*
  • Spiro Compounds / pharmacology
  • Streptomyces / chemistry*

Substances

  • Anti-Bacterial Agents
  • Antineoplastic Agents
  • Lactams
  • Oxazoles
  • Polyunsaturated Alkamides
  • Spiro Compounds
  • lajollamycin
  • curromycin B